OVERVIEW
- Hyperosmolar hyperglycaemic state (HHS) = Hyperosmotic Hyperglycaemic Syndrome (HHS)
- three times less frequent than DKA
- deaths often due to co-morbid conditions (MI)
- higher mortality rate than DKA
- part of a continuum with DKA, with insulin resistance predominant over insulin deficiency
PATHOPHYSIOLOGY
- acute stressor/triggers:
- infection – half of patients (common sources include pneumonia, urinary tract)
- Pancreatitis, trauma, heat exposure
- MI
- Insulin nonadherence or inadequate dosing
- Surgery
- Medication changes (glucocorticoid, thiazides, phenytoin, beta-blockers, anti-calcineurin immunosuppressives, HIV protease inhibitors, antipsychotics)
- increases levels of cortisol and catecholamines –>
- decreased insulin sensitivity
- decreased insulin
- -> decreased glucose utilisation in skeletal muscle, increased fat and muscle breakdown
- has enough insulin to prevent ketoacidosis/ketone production
- but not enough insulin to control hyperglycemia
- increased hepatic gluconeogenesis
- increase in glucagon, cortisol, catecholamines
- increased BSL
- glycosuria + osmotic diuresis –> loss of water
- Patients fail to compensate adequately for water loss by increasing oral water intake (e.g., due to baseline debility, bed-bound status, or a relatively insensitive central drive to maintain normal tonicity).
- Over a period of several days, uncontrolled water loss leads to a hypertonic state. This may lead to altered mental status (which exacerbates the patient’s inability to drink an adequate amount of water)
HISTORY
- polydipsia
- polyuria
- weight loss
- weakness
- slow onset
- progressive dehydration
- coma
- causes: MI, infection, diuretics, CVA, PE
RISK FACTORS
- elderly
- type II DM
- mental obtundation/dementia
- physical impairment limiting access to H2O
- renal dysfunction
- inappropriate diuretic use
- steroids
- beta-blockers
- phenytoin
EXAMINATION
- CVS – tachycardia, decreased skin turgor, sunken eyes, dry mouth
- RESP – tachypnoea
- CNS – drowsy, delirium, coma, focal or generalised seizures, visual changes, hemiparesis
INVESTIGATIONS
- very high osmolarity (> 320mosmol/kg)
- very high glucose
- little or no ketonuria (beta-hydroxybutyrate)
- hyponatraemia (or pseudohyponatraemia -> hyperglycaemia draws water out of cells) or hypernatraemia
- hypokalaemia
- hypomagnesaemia
- ABG:
- pH normally > 7.3 (metabolic acidosis is not severe)
- normal anion gap
- Beta-hydroxybutyrate level (most precise way to quantify the presence and severity of ketoacidosis)
- normal level of ketones
- renal dysfunction commonly present
Diagnostic Criteria
- serum osmolarity > 320mosmol/L
- serum glucose > 33mmol/L
- profound dehydration (elevated urea:creatinine ratio)
- no ketoacidosis
Investigations for cause
- CXR: chest infection
- compliance with medication
- ECG + TNT: MI
- FBC
- CRP
- blood cultures
- urine
MANAGEMENT
- HHS is a deranged state which develops gradually over days to weeks.
- However, these patients generally adapt to their new state and often tolerate it relatively well.
- As a general rule of thumb, if an abnormal state develops gradually then it may be treated gradually.
- The primary risk of treating HHS is overly aggressive therapy, which may cause dangerous swings in electrolyte levels and osmolality.
- When in doubt, the safest approach to HHS is generally to correct abnormalities slowly.
- Goals
- correct dehydration (often 6-9 L of H2O loss)
- provide insulin
- replace electrolytes
- correct metabolic acidosis
Resuscitation
- A – may require intubation if coma and not protecting airway
- B – mechanical ventilation can minimise WOB and manage possible metabolic acidosis
- C – resuscitate with isotonic fluid until patient has a normal heart rate and BP (see below for H2O replacement) or can use colloids.
Treatment
- Calculate corrected Na+
- if hypernatraemic, the corrected Na+ = measured Na+ + glucose/3
- monitor this as Na+ changes for glucose
- Calculate H2O deficit
- H2O deficit = 0.6 x premorbid weight x (1 – 140/corrected Na+)
- Fluid management in first 24 hours
- maintenance as D5W at standard rate
- if hypernatraemic: replace half the H2O deficit over 24 hours using ½ normal saline.
- Monitor Na+ closely – should not change more than 10mmol in 24 hours
- Replace other electrolytes as required
- K+ (often require aggressive replacement – 10-20mmol/hr, make sure not anuric)
- Mg2+ – Magnesium should be aggressively repleted.magnesium level on the high end will tend to prevent Torsade de Pointes if the potassium level falls.
- PO4 – Phosphate should be repleted as necessary
- Ca2+
- Fluid management in second 24 hours
- when glucose < 15mmol/L -> use D5W @ 100-250mL/hr AND saline
- keep Na+ between 140-150mmol/L
- the metabolic acidosis rarely requires specific treatment as responds to volume expansion and insulin therapy.
- General
- insulin at 0.05 U/kg/h
- do not allow blood glucose to drop by more than 3 mmol/L/h
- once glucose <15mmol/L and corrected Na+ 10% dextrose
- thromboprophylaxis (SCD’s, clexane, TEDS) -> high risk of VTE
- diagnose cause and treat: infection, compliance, MI, CVA
- Complication Management
- delirium -> coma
- cerebral oedema (prevent by resuscitation with isotonic fluid and slow correction of glucose)
- seizures (focal and generalized)
- severe dehydration and shock
- renal failure
- thrombotic complications: VTE, stroke, AMI
- intercurrent events: sepsis, MI, aspiration
- occlusive events: focal CNS signs, chorea, DIC, leg ischaemia, rhabdomyolysis
- fluid overload and congestive heart failure
- metabolic derangement: hypokalaemia, hypophosphataemia, hypomagnesaemia, hypoglycaemia, hyperchloraemia with NAGMA